149 related articles for article (PubMed ID: 26087186)
1. Regulation of migration and invasion by Toll-like receptor-9 signaling network in prostate cancer.
Luo Y; Jiang QW; Wu JY; Qiu JG; Zhang WJ; Mei XL; Shi Z; Di JM
Oncotarget; 2015 Sep; 6(26):22564-74. PubMed ID: 26087186
[TBL] [Abstract][Full Text] [Related]
2. Expression of toll-like receptor-9 is increased in poorly differentiated prostate tumors.
Väisänen MR; Väisänen T; Jukkola-Vuorinen A; Vuopala KS; Desmond R; Selander KS; Vaarala MH
Prostate; 2010 Jun; 70(8):817-24. PubMed ID: 20054821
[TBL] [Abstract][Full Text] [Related]
3. TLR9 signaling through NF-κB/RELA and STAT3 promotes tumor-propagating potential of prostate cancer cells.
Moreira D; Zhang Q; Hossain DM; Nechaev S; Li H; Kowolik CM; D'Apuzzo M; Forman S; Jones J; Pal SK; Kortylewski M
Oncotarget; 2015 Jul; 6(19):17302-13. PubMed ID: 26046794
[TBL] [Abstract][Full Text] [Related]
4. Toll-like receptor 9 mediates invasion and predicts prognosis in squamous cell carcinoma of the mobile tongue.
Kauppila JH; Korvala J; Siirilä K; Manni M; Mäkinen LK; Hagström J; Atula T; Haglund C; Selander KS; Saarnio J; Karttunen TJ; Lehenkari PP; Salo T
J Oral Pathol Med; 2015 Sep; 44(8):571-7. PubMed ID: 25338738
[TBL] [Abstract][Full Text] [Related]
5. Toll like receptor-9 agonists stimulate prostate cancer invasion in vitro.
Ilvesaro JM; Merrell MA; Swain TM; Davidson J; Zayzafoon M; Harris KW; Selander KS
Prostate; 2007 May; 67(7):774-81. PubMed ID: 17373717
[TBL] [Abstract][Full Text] [Related]
6. Cell-free DNA derived from cancer cells facilitates tumor malignancy through Toll-like receptor 9 signaling-triggered interleukin-8 secretion in colorectal cancer.
Niu Z; Tang W; Liu T; Xu P; Zhu D; Ji M; Huang W; Ren L; Wei Y; Xu J
Acta Biochim Biophys Sin (Shanghai); 2018 Oct; 50(10):1007-1017. PubMed ID: 30239551
[TBL] [Abstract][Full Text] [Related]
7. Small interfering RNA-directed targeting of Toll-like receptor 4 inhibits human prostate cancer cell invasion, survival, and tumorigenicity.
Hua D; Liu MY; Cheng ZD; Qin XJ; Zhang HM; Chen Y; Qin GJ; Liang G; Li JN; Han XF; Liu DX
Mol Immunol; 2009 Sep; 46(15):2876-84. PubMed ID: 19643479
[TBL] [Abstract][Full Text] [Related]
8. Gallic acid suppresses the migration and invasion of PC-3 human prostate cancer cells via inhibition of matrix metalloproteinase-2 and -9 signaling pathways.
Liu KC; Huang AC; Wu PP; Lin HY; Chueh FS; Yang JS; Lu CC; Chiang JH; Meng M; Chung JG
Oncol Rep; 2011 Jul; 26(1):177-84. PubMed ID: 21503582
[TBL] [Abstract][Full Text] [Related]
9. Chloroquine inhibits MGC803 gastric cancer cell migration via the Toll-like receptor 9/nuclear factor kappa B signaling pathway.
Zhang Y; Li Y; Li Y; Li R; Ma Y; Wang H; Wang Y
Mol Med Rep; 2015 Feb; 11(2):1366-71. PubMed ID: 25369757
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-494-3p targets CXCR4 to suppress the proliferation, invasion, and migration of prostate cancer.
Shen PF; Chen XQ; Liao YC; Chen N; Zhou Q; Wei Q; Li X; Wang J; Zeng H
Prostate; 2014 May; 74(7):756-67. PubMed ID: 24644030
[TBL] [Abstract][Full Text] [Related]
11. Study of TLR3, TLR4, and TLR9 in prostate carcinomas and their association with biochemical recurrence.
González-Reyes S; Fernández JM; González LO; Aguirre A; Suárez A; González JM; Escaff S; Vizoso FJ
Cancer Immunol Immunother; 2011 Feb; 60(2):217-26. PubMed ID: 20978888
[TBL] [Abstract][Full Text] [Related]
12. Toll-like receptor 9 expression in mucoepidermoid salivary gland carcinoma may associate with good prognosis.
Korvala J; Harjula T; Siirilä K; Almangush A; Aro K; Mäkitie AA; Grénman R; Karttunen TJ; Leivo I; Kauppila JH; Salo T
J Oral Pathol Med; 2014 Aug; 43(7):530-7. PubMed ID: 24484266
[TBL] [Abstract][Full Text] [Related]
13. Toll-like receptor 9 agonists promote cellular invasion by increasing matrix metalloproteinase activity.
Merrell MA; Ilvesaro JM; Lehtonen N; Sorsa T; Gehrs B; Rosenthal E; Chen D; Shackley B; Harris KW; Selander KS
Mol Cancer Res; 2006 Jul; 4(7):437-47. PubMed ID: 16849519
[TBL] [Abstract][Full Text] [Related]
14. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas.
Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y
Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701
[TBL] [Abstract][Full Text] [Related]
15. CX3CL1 increases invasiveness and metastasis by promoting epithelial-to-mesenchymal transition through the TACE/TGF-α/EGFR pathway in hypoxic androgen-independent prostate cancer cells.
Tang J; Xiao L; Cui R; Li D; Zheng X; Zhu L; Sun H; Pan Y; Du Y; Yu X
Oncol Rep; 2016 Feb; 35(2):1153-62. PubMed ID: 26718770
[TBL] [Abstract][Full Text] [Related]
16. Expression and functional role of CCR9 in prostate cancer cell migration and invasion.
Singh S; Singh UP; Stiles JK; Grizzle WE; Lillard JW
Clin Cancer Res; 2004 Dec; 10(24):8743-50. PubMed ID: 15623660
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptor 9 mediates CpG oligonucleotide-induced cellular invasion.
Ilvesaro JM; Merrell MA; Li L; Wakchoure S; Graves D; Brooks S; Rahko E; Jukkola-Vuorinen A; Vuopala KS; Harris KW; Selander KS
Mol Cancer Res; 2008 Oct; 6(10):1534-43. PubMed ID: 18922969
[TBL] [Abstract][Full Text] [Related]
18. Toll-like receptor 9 agonists promote IL-8 and TGF-beta1 production via activation of nuclear factor kappaB in PC-3 cells.
Di JM; Pang J; Pu XY; Zhang Y; Liu XP; Fang YQ; Ruan XX; Gao X
Cancer Genet Cytogenet; 2009 Jul; 192(2):60-7. PubMed ID: 19596255
[TBL] [Abstract][Full Text] [Related]
19. Crude extract of Euphorbia formosana inhibits the migration and invasion of DU145 human prostate cancer cells: The role of matrix metalloproteinase-2/9 inhibition via the MAPK signaling pathway.
Yang JL; Lin JH; Weng SW; Chen JC; Yang JS; Amagaya S; Funayana S; Wood WG; Kuo CL; Chung JG
Mol Med Rep; 2013 May; 7(5):1403-8. PubMed ID: 23525212
[TBL] [Abstract][Full Text] [Related]
20. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
